BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33741274)

  • 1. Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity.
    Serban M; de Leeuw AAC; Tanderup K; Jürgenliemk-Schulz IM
    Brachytherapy; 2021; 20(3):565-575. PubMed ID: 33741274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
    Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
    Hsu IC; Speight J; Hai J; Vigneault E; Phillips T; Pouliot J
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):538-43. PubMed ID: 11872302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
    Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
    Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies.
    Bajwa HK; Singareddy R; Krishnam Raju A
    Brachytherapy; 2020; 19(5):669-673. PubMed ID: 32466952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
    Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
    Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
    Westerveld H; Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Spampinato S; Sturdza A; Nesvacil N; Bruheim K; Hellebust TP; Pieters BR; Kirisits C; Jürgenliemk-Schulz IM; Pötter R; de Leeuw AAC
    Radiother Oncol; 2022 Mar; 168():8-15. PubMed ID: 35063582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
    Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
    Singh A; Mani N; Aggarwal LM; Agarwal S; Mourya A; Verma A; Bagchi A; Gupta N; Choudhary S
    Brachytherapy; 2023; 22(5):616-622. PubMed ID: 37286402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
    Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
    Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix.
    Katz A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1417-25. PubMed ID: 11121642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
    Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
    Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
    Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
    Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
    Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator.
    Berger D; Dimopoulos J; Georg P; Georg D; Pötter R; Kirisits C
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1451-9. PubMed ID: 17289290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer.
    Mai J; Erickson B; Rownd J; Gillin M
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1131-41. PubMed ID: 11704338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
    Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.
    Serban M; Fokdal L; Nielsen SK; Hokland SB; Hansen AT; Spejlborg H; Rylander S; Petric P; Lindegaard JC; Tanderup K
    Brachytherapy; 2021; 20(4):796-806. PubMed ID: 33994344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.